Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Avacostar - A Post Authorization Safety Study (PASS) to Evaluate the Incidence of Safety Events of Interest in Patients Treated With Avacopan for ANCA-associated Vasculitis (AAV)

NCT05897684 is registered in ClinicalTrials.gov with Vifor Fresenius Medical Care Renal Pharma as lead sponsor.

NCT NCT05897684
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05897684 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Avacostar - A Post Authorization Safety Study (PASS) to Evaluate the Incidence of Safety Events of Interest in Patients Treated With Avacopan for ANCA-associated Vasculitis (AAV)
Lead sponsor
Vifor Fresenius Medical Care Renal Pharma
Phase
Observational
Overall status
Active, not recruiting
Start date
September 11, 2023
Completion date
December 1, 2030
Enrollment
507 (actual)
Sites
35

Conditions

As the registry lists them; a condition with its own page is linked.

anca-associated vasculitis